CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases | Zendy

Jun Hee Lee | Zendy; Sang Hun Lee | Zendy; So Young Yoo | Zendy; Takayuki Asahara | Zendy; SangMo Kwon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases

Author(s) -

Jun Hee Lee,

Sang Hun Lee,

So Young Yoo,

Takayuki Asahara,

SangMo Kwon

Publication year - 2013

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.112.301052

Subject(s) - microbiology and biotechnology , progenitor cell , stem cell , endothelial progenitor cell , cd34 , endothelial stem cell , haematopoiesis , biology , hematopoietic stem cell , immunology , chemistry , cancer research , in vitro , biochemistry

Although endothelial progenitor cells (EPCs) have been reported to promote neovessel formation during vascular injury, the function of supporting cells of EPCs and their interaction with EPCs during EPC isolation remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research